Adial Pharmaceuticals

$2.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.38%) As of 3:44 PM UTC today

Why Robinhood?

You can buy or sell ADIL and other stocks, options, and ETFs commission-free!

About ADIL

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist.

CEO
William B. Stilley
Employees
9
Headquarters
Charlottesville, Virginia
Founded
2010
Market Cap
38.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
178.28K
High Today
$2.23
Low Today
$2.09
Open Price
$2.20
Volume
57.81K
52 Week High
$4.00
52 Week Low
$1.14

ADIL Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

SMFKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure